Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Number of Reportable Segments

2.8 / 5 stars · 68/120 Roast Me

NIAGEN BIOSCIENCE, INC. Number of Reportable Segments

NIAGEN BIOSCIENCE, INC. (NAGE) reported Number of Reportable Segments of 4 reportable_segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Notes

us-gaap:NumberOfReportableSegments · last filed 2026-08-04

  • NIAGEN BIOSCIENCE, INC. number of reportable segments for the quarter ending 2026-03-31 was 4.00 reportable_segment, a 33.33% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. number of reportable segments for the quarter ending 2025-03-31 was 3.00 reportable_segment, a 0.00% change year-over-year.
  • NIAGEN BIOSCIENCE, INC. number of reportable segments for the quarter ending 2024-03-31 was 3.00 reportable_segment, a 0.00% change year-over-year.
  • NIAGEN BIOSCIENCE, INC. number of reportable segments for the quarter ending 2023-03-31 was 3.00 reportable_segment, a 0.00% change year-over-year.
  • NIAGEN BIOSCIENCE, INC. number of reportable segments for fiscal 2025 was 4.00 reportable_segment, a 33.33% increase from fiscal 2024.
  • NIAGEN BIOSCIENCE, INC. number of reportable segments for fiscal 2024 was 3.00 reportable_segment, a 0.00% change from fiscal 2023.
  • NIAGEN BIOSCIENCE, INC. number of reportable segments for fiscal 2023 was 3.00 reportable_segment, a 0.00% change from fiscal 2022.
  • NIAGEN BIOSCIENCE, INC. number of reportable segments for fiscal 2022 was 3.00 reportable_segment, a 0.00% change from fiscal 2021.
Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 month
2026-06-304.00 reportable_segment
10-Q · filed 2026-08-04
2026-03-314.00 reportable_segment
10-Q · filed 2026-05-06
2025-12-314.00 reportable_segment
10-K · filed 2026-03-04
2025-09-303.00 reportable_segment
10-Q · filed 2025-11-04
2025-06-303.00 reportable_segment
10-Q · filed 2025-08-06
2025-03-313.00 reportable_segment
10-Q · filed 2025-05-07
2024-12-313.00 reportable_segment
10-K · filed 2025-03-04
2024-09-303.00 reportable_segment
10-Q · filed 2024-10-31
2024-06-303.00 reportable_segment
10-Q · filed 2024-08-07
2024-03-313.00 reportable_segment
10-Q · filed 2024-05-08
2023-12-313.00 reportable_segment
10-K · filed 2025-03-04
2023-09-303.00 reportable_segment
10-Q · filed 2023-11-08
2023-06-303.00 reportable_segment
10-Q · filed 2023-08-09
2023-03-313.00 reportable_segment
10-Q · filed 2023-05-10
2022-12-313.00 reportable_segment
10-K · filed 2024-03-06
2022-09-303.00 reportable_segment
10-Q · filed 2022-11-02
2022-06-303.00 reportable_segment
10-Q · filed 2022-08-10
2022-03-313.00 reportable_segment
10-Q · filed 2022-05-12
2021-12-313.00 reportable_segment
10-K · filed 2023-03-08
2021-09-303.00 reportable_segment
10-Q · filed 2021-11-03
2021-06-303.00 reportable_segment
10-Q · filed 2021-08-03
2020-12-313.00 reportable_segment
10-K · filed 2022-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87